More recent work implicated LRP4 as an additional player in MG pathology; MG patients that displayed symptoms consistent with the motor disorder, but were double seronegative against MuSK and AChR, instead had autoantibodies against LRP4 [28,101]. This evidence concerns the gene LRP4 and myasthenia gravis.